Literature DB >> 26885443

The association of mammalian DREAM complex and HPV16 E7 proteins.

Nurshamimi Nor Rashid1, Hussin A Rothan1, Mohd Shahrizal Mohd Yusoff1.   

Abstract

The mammalian DREAM (Drosophila, RB, E2F, and Myb) complex was discovered in 2004 by several research groups. It was initially identified in Drosophila followed by Caenorhaditis elegans and later in mammalian cells. The composition of DREAM is temporally regulated during cell cycle; being associated with E2F-4 and either p107 or p130 in G0/G1 (repressive DREAM complexes) and with B-myb transcription factor in S/G2 (activator DREAM complex). High risk human papillomavirus (HPV) E6 and E7 oncoproteins expression are important for malignant transformation of cervical cancer cells. In particular, the E7 of high risk HPV binds to pRB family members (pRB, p107 and p130) for degradation. It has recently been discovered that the p107 and p130 'pocket proteins' are members of mammalian DREAM complexes. With this understanding, we would like to hypothesise the mammalian DREAM complex could plays a critical role for malignant transformation in cervical cancer cells.

Entities:  

Keywords:  CaSki cell lines; E7 proteins; Human papillomavirus 16; mammalian DREAM complex

Year:  2015        PMID: 26885443      PMCID: PMC4731628     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  74 in total

Review 1.  Ubiquitin-mediated proteolysis: biological regulation via destruction.

Authors:  A Ciechanover; A Orian; A L Schwartz
Journal:  Bioessays       Date:  2000-05       Impact factor: 4.345

Review 2.  SCF and Cullin/Ring H2-based ubiquitin ligases.

Authors:  R J Deshaies
Journal:  Annu Rev Cell Dev Biol       Date:  1999       Impact factor: 13.827

3.  Native E2F/RBF complexes contain Myb-interacting proteins and repress transcription of developmentally controlled E2F target genes.

Authors:  Michael Korenjak; Barbie Taylor-Harding; Ulrich K Binné; John S Satterlee; Olivier Stevaux; Rein Aasland; Helen White-Cooper; Nick Dyson; Alexander Brehm
Journal:  Cell       Date:  2004-10-15       Impact factor: 41.582

Review 4.  B-MYB, a transcription factor implicated in regulating cell cycle, apoptosis and cancer.

Authors:  Arturo Sala
Journal:  Eur J Cancer       Date:  2005-09-29       Impact factor: 9.162

5.  Differential regulation of the pocket domains of the retinoblastoma family proteins by the HPV16 E7 oncoprotein.

Authors:  E Berezutskaya; B Yu; A Morozov; P Raychaudhuri; S Bagchi
Journal:  Cell Growth Differ       Date:  1997-12

6.  Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.

Authors:  M Bessa; M K Saville; R J Watson
Journal:  Oncogene       Date:  2001-06-07       Impact factor: 9.867

7.  Human papillomavirus type 16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation.

Authors:  R Davies; R Hicks; T Crook; J Morris; K Vousden
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

8.  Over-expression of FOXM1 transcription factor is associated with cervical cancer progression and pathogenesis.

Authors:  D W Chan; S Y M Yu; P M Chiu; K M Yao; V W S Liu; A N Y Cheung; H Y S Ngan
Journal:  J Pathol       Date:  2008-07       Impact factor: 7.996

9.  Protein domains governing interactions between E2F, the retinoblastoma gene product, and human papillomavirus type 16 E7 protein.

Authors:  P S Huang; D R Patrick; G Edwards; P J Goodhart; H E Huber; L Miles; V M Garsky; A Oliff; D C Heimbrook
Journal:  Mol Cell Biol       Date:  1993-02       Impact factor: 4.272

10.  HPV16 E7 oncoprotein deregulates B-myb expression: correlation with targeting of p107/E2F complexes.

Authors:  E W Lam; J D Morris; R Davies; T Crook; R J Watson; K H Vousden
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

View more
  11 in total

1.  Inhibitory Effect of Vaginal Lactobacillus Supernatants on Cervical Cancer Cells.

Authors:  Ke-Di Wang; Dong-Jiang Xu; Bao-Ya Wang; Dong-Hui Yan; Zhi Lv; Jian-Rong Su
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

2.  Infection of Bronchial Epithelial Cells by the Human Adenoviruses A12, B3, and C2 Differently Regulates the Innate Antiviral Effector APOBEC3B.

Authors:  Noémie Lejeune; Florian Poulain; Kévin Willemart; Zoé Blockx; Sarah Mathieu; Nicolas A Gillet
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

3.  Human Papillomavirus 16 E7 Stabilizes APOBEC3A Protein by Inhibiting Cullin 2-Dependent Protein Degradation.

Authors:  Joseph A Westrich; Cody J Warren; Michael J Klausner; Kejun Guo; Chang-Wei Liu; Mario L Santiago; Dohun Pyeon
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 4.  Human Papillomavirus E6 and E7: The Cervical Cancer Hallmarks and Targets for Therapy.

Authors:  Asmita Pal; Rita Kundu
Journal:  Front Microbiol       Date:  2020-01-21       Impact factor: 5.640

Review 5.  Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins.

Authors:  Daria A Haręża; Jacek R Wilczyński; Edyta Paradowska
Journal:  Int J Mol Sci       Date:  2022-02-05       Impact factor: 5.923

6.  Oncogenic Viruses as Entropic Drivers of Cancer Evolution.

Authors:  Italo Tempera; Paul M Lieberman
Journal:  Front Virol       Date:  2021-11-15

Review 7.  Head and Neck Cancer Susceptibility and Metabolism in Fanconi Anemia.

Authors:  Tafadzwa Chihanga; Sara Vicente-Muñoz; Sonya Ruiz-Torres; Bidisha Pal; Mathieu Sertorio; Paul R Andreassen; Ruby Khoury; Parinda Mehta; Stella M Davies; Andrew N Lane; Lindsey E Romick-Rosendale; Susanne I Wells
Journal:  Cancers (Basel)       Date:  2022-04-18       Impact factor: 6.575

8.  Proteasomal degradation of p130 facilitate cell cycle deregulation and impairment of cellular differentiation in high-risk Human Papillomavirus 16 and 18 E7 transfected cells.

Authors:  Sivasangkary Gandhi; Nurshamimi Nor Rashid; Muhammad Fazril Mohamad Razif; Shatrah Othman
Journal:  Mol Biol Rep       Date:  2021-06-24       Impact factor: 2.316

9.  Synergistic Carcinogenesis of HPV18 and MNNG in Het-1A Cells through p62-KEAP1-NRF2 and PI3K/AKT/mTOR Pathway.

Authors:  Ying Zhang; Yue Ma; Chao Zhao; Hu Zhang; Yuepu Pu; Lihong Yin
Journal:  Oxid Med Cell Longev       Date:  2020-10-09       Impact factor: 6.543

10.  Characterization of the mechanism by which the RB/E2F pathway controls expression of the cancer genomic DNA deaminase APOBEC3B.

Authors:  Chai Yeen Goh; Boon Haow Chua; Pieter A Roelofs; Matthew C Jarvis; Teneale A Stewart; Jennifer L McCann; Rebecca M McDougle; Michael A Carpenter; John Wm Martens; Paul N Span; Dennis Kappei; Reuben S Harris
Journal:  Elife       Date:  2020-09-28       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.